How much does Imbruvica (Ibrutinib Capsules) Cost& price without insurance in China?
Imbruvica® is the commercial brand name of Ibrutinib Capsules, an orally active Bruton’s tyrosine kinase (BTK) inhibitor developed by Pharmacyclics. It covalently binds to BTK, blocking B-cell receptor signaling pathways to inhibit B-cell proliferation and survival.
Main Indications
Treatment of chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), mantle cell lymphoma (MCL), Waldenström’s macroglobulinemia (WM), and marginal zone lymphoma (MZL).
Common Side Effects
Common mild adverse reactions: Diarrhea, fatigue, nausea, bruising, and upper respiratory tract infections.
Laboratory abnormalities: Thrombocytopenia, neutropenia, anemia, and elevated liver enzymes.
Severe but uncommon risks: Severe hemorrhage, atrial fibrillation, infection, and secondary malignancies.
Approval Status in China
Imbruvica® (Ibrutinib Capsules, 140mg) was officially approved for marketing in China in 2017. It is currently a prescription anti-tumor drug included in China’s Category B medical insurance.
Buy Imbruvica (Ibrutinib Capsules) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
